Northover AM |
Modification by some antagonists of the shape changes of venous endothelial cells in response to inflammatory agents in vitro. |
1990 |
Agents Actions |
pmid:2111079
|
McLeod J et al. |
Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on substance P-induced histamine release from rat peritoneal mast cells. |
1990 |
Agents Actions |
pmid:1695435
|
Trebien HA and Calixto JB |
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. |
1989 |
Agents Actions |
pmid:2660497
|
Bekemeier H and Sänze JU |
Vasodepression ex vivo after administration of inflammatory mediators in vivo in the rat. |
1989 |
Agents Actions |
pmid:2476918
|
Jouquey S et al. |
Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. |
1988 |
Agents Actions |
pmid:2459935
|
Sanchez Crespo M and Nieto ML |
Modulation of PAF biosynthesis in human polymorphonuclear leukocytes. The role of phorbol esters and protein kinases. |
1989 |
Agents Actions |
pmid:2711927
|
Zijlstra FJ et al. |
The effects of PAF-acether and FMLP on eicosanoid production in guinea pig alveolar macrophages. |
1989 |
Agents Actions |
pmid:2711928
|
Nijkamp FP et al. |
Role of platelet activating factor in the endotoxin induced tracheal hyperreactivity to histamine in the guinea pig. |
1989 |
Agents Actions |
pmid:2711929
|
Oliver JL et al. |
Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF. |
1989 |
Agents Actions |
pmid:2711930
|
Nieminen MM et al. |
Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit. |
1991 |
Agents Actions |
pmid:1862740
|
Jenei B et al. |
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function). |
1991 |
Agents Actions |
pmid:1862750
|
Kantar A et al. |
Effect of PAF on erythrocyte membrane heterogeneity: a fluorescence study. |
1991 |
Agents Actions |
pmid:1862752
|
Carlson RP et al. |
Pharmacologic modulation of PAF-induced mortality in mice. |
1987 |
Agents Actions |
pmid:3120513
|
Anderson GP et al. |
Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. |
1988 |
Agents Actions |
pmid:3136622
|
Perales J et al. |
Neutralization of the oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. |
1992 |
Agents Actions |
pmid:1295374
|
Raff GW et al. |
Procoagulant property of platelet activating factor (PAF). |
1993 |
Agents Actions |
pmid:8273543
|
Meats JE et al. |
Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. |
1993 |
Agents Actions |
pmid:8273553
|
Thomas TK et al. |
Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat. |
1993 |
Agents Actions |
pmid:8273566
|
Glaser KB et al. |
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). |
1993 |
Agents Actions |
pmid:8273577
|
Heller R et al. |
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. |
1993 |
Agents Actions |
pmid:7517616
|